More articles from 03.03 - Mechanisms of lung injury and repair

Human induced pluripotent stem cell-derived alveolar type 2 cells mature at air-liquid interface and respond to airborne stimuli
K Abo, A Wilson

European Respiratory Journal Sep 2022, 60 (suppl 66) 4648; DOI: 10.1183/13993003.congress-2022.4648
A novel neuropilin-2 (NRP2) antibody for immunohistochemical staining of patient tissue samples
Y Chong, S Förster, D Siefker, Y Becker, E Escobedo, L Burman, K Rauch, S Paz, C Burkart, A Cubitt, M Muders, L Nangle

European Respiratory Journal Sep 2022, 60 (suppl 66) 4531; DOI: 10.1183/13993003.congress-2022.4531
CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges
L Biebach, S Cindric, J Koenig, I Aprea, G Dougherty, J Raidt, D Bracht, R Ruppel, J Schreiber, R Hjeij, H Olbrich, H Omran

European Respiratory Journal Sep 2022, 60 (suppl 66) 4522; DOI: 10.1183/13993003.congress-2022.4522
Febuxostat inhibits inflammation and fibrosis in a murine model of LPS-induced lung injury
S Ohta, H Ikeda, T Ebato, H Inoue, T Homma, S Suzuki, A Tanaka, H Sagara

European Respiratory Journal Sep 2022, 60 (suppl 66) 4450; DOI: 10.1183/13993003.congress-2022.4450
Exposure to particulate matter alters neutrophil lysosomal function and activation status
E Watts, R Huff, C Rider, M Whyte, S Walmsley, C Carlsten

European Respiratory Journal Sep 2022, 60 (suppl 66) 4686; DOI: 10.1183/13993003.congress-2022.4686
Spatially resolved transcriptomics of human and mouse fibrotic lung
L Franzén, M Olsson Lindvall, S Jackson, G Hamm, B Keith, S Oag, A Collin, J Cann, J Lindgren, G Belfield, A Ollerstam, M Stamou, P Ståhl, J Hornberg

European Respiratory Journal Sep 2022, 60 (suppl 66) 4609; DOI: 10.1183/13993003.congress-2022.4609
Parenchymal lung abnormalities, clinical severity and outcomes in patients with COVID 19 pneumonia: a prospective longitudinal observational study
A K Prakash, B Datta, M K Singh, K Yaddanapudi, K Ahlawat, J Tripathy, P Goyal, S Mittal, N Gupta, S Parvathi, A Jaiswal, P Singh, S Pipavat, G Raghu

European Respiratory Journal Sep 2022, 60 (suppl 66) 4480; DOI: 10.1183/13993003.congress-2022.4480
Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling
P P S J Khedoe, L Jia, N Li, P S Hiemstra, F Koning, J Stolk

European Respiratory Journal Sep 2022, 60 (suppl 66) LSC-0195; DOI: 10.1183/13993003.congress-2022.LSC-0195
Ex vivo modelling of human lung fibrogenesis and drug mode of action screens using single-cell RNA-seq in precision-cut lung slices
N Lang, M Ansari, D Porras-Gonzalez, A Agami, B Hooshiar Kashani, S Zhou, L Yang, M Gerckens, X Wei, C H Mayr, J Schniering, M Stoleriu, R Hatz, J Behr, G Burgstaller, H B Schiller

European Respiratory Journal Sep 2022, 60 (suppl 66) LSC-0072; DOI: 10.1183/13993003.congress-2022.LSC-0072
Airway morphogenesis in wild type and heterozygous F508del mouse embryonic lungs treated by Elexacaftor/Tezacaftor/Ivacaftor
A Hadchouel-Duvergé, M Lhuillier, L Aoust, E Dreano, K Landry Truchon, C Delacourt, L Jeanotte, I Sermet Gaudelus

European Respiratory Journal Sep 2022, 60 (suppl 66) 4330; DOI: 10.1183/13993003.congress-2022.4330

Main menu

User menu

Search

More articles from 03.03 - Mechanisms of lung injury and repair

Pages

Contact us